Showing 101-110 of 5947 results for "".
First Medication for Severe Frostbite; Biosimilar to Humira with Interchangeability Status Approved; Two Late-Stage AD Candidates Advance
https://practicaldermatology.com/series/dermwire-tv/first-medication-for-severe-frostbite-biosimilar-to-humira-with-interchangeability-status-approved-two-late-stage-ad-candidates-advance/20267/In this episode of DermWireTV, the first medication to treat severe frostbite is approved by the FDA; the first high-concentration biosimilar to Humira with interchangeability status will soon be available in the US; and two companies with late-stage atopic dermatitis candidates provide key updates.Can AI and Digital Innovation Improve the Patient Experience?
https://practicaldermatology.com/topics/practice-management/can-ai-and-digital-innovation-improve-the-patient-experience/23964/Embrace AI and how it can help improve points of contact with your patients.Identifying SCC Risk
https://practicaldermatology.com/topics/skin-cancer-photoprotection/identifying-scc-risk/20144/Sherrif Ibrahim, MD discusses the challenges of managing squamous cell carcinoma (SCC). Great steps have been made in clinical, pathological staging systems, but Dr. Ibrahim says it’s still difficult to determine what to do with borderline cases. He talks about the need to determine frequency and inIn the Pipeline: New Approaches to Vitiligo, Congenital Ichthyosis, and More
https://practicaldermatology.com/topics/pigmentary-disorders/in-the-pipeline-new-approaches-to-vitiligo-congenital-ichthyosis-and-more/23714/Inflammatory diseases with few or no specific treatments may soon have approved interventions.DermWireTV: Cutera, Galderma Acne Treatments; Alma's TED; Diversity Initiatives
https://practicaldermatology.com/topics/practice-management/dermwiretv-cutera-galderma-acne-treatments-almas-ted-diversity-initiatives/20084/There are two new options for treating acne. Cutera introduces the AviClear acne device; Galderma launches Twyneo Cream. Joshua Zeichner, MD weighs in. Lady Dy, MD discusses Alma’s TED device, a non-invasive, non-traumatic option to address hair loss. New initiatives announced at or in conjunction wEBD Insights
https://practicaldermatology.com/conferences/maui-derm-2022/ebd-insights/20049/There are a number of new and reliable energy-based devices available. Michael H. Gold, MD discusses tried-and-true technologies as well as new and innovative devices that offer efficacious options on the market for a variety of dermatologic needs.DermWireTV: Updates from ASDS: EBDs, Injectables, Scars, DEI
https://practicaldermatology.com/topics/practice-management/dermwiretv-updates-from-asds-ebds-injectables-scars-dei/20029/The annual meeting of the American Society for Dermatology Surgery (ASDS) brings together top dermatologists to share their expertise. This year’s virtual meeting offered a look at a range of new and emerging treatments and some updates on existing options, including insights from Jeanine B. Downie,Backdoor Roth IRA Strategy in 2021
https://practicaldermatology.com/topics/practice-management/backdoor-roth-ira-strategy-in-2021/23480/As tax increases may come for high-income earners, we offer an effective step toward tax diversification.Permanent Life Insurance, Part 2
https://practicaldermatology.com/topics/practice-management/permanent-life-insurance-part-2/23462/Who should use it and how, and who should not utilize this type of insurance.Permanent Life Insurance: What It Is and Why a New Law Has Made It Better
https://practicaldermatology.com/topics/practice-management/permanent-life-insurance-what-it-is-and-why-a-new-law-has-made-it-better/23443/A review of what this insurance offers.